16-31061069-C-T
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_024706.5(ZNF668):c.1859G>A(p.Ter620=) variant causes a stop retained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00374 in 1,491,286 control chromosomes in the GnomAD database, including 170 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 106 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 64 hom. )
Consequence
ZNF668
NM_024706.5 stop_retained
NM_024706.5 stop_retained
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0780
Genes affected
ZNF668 (HGNC:25821): (zinc finger protein 668) Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
?
Variant 16-31061069-C-T is Benign according to our data. Variant chr16-31061069-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 786291.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
?
Synonymous conserved (PhyloP=-0.078 with no splicing effect.
BA1
?
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0681 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF668 | NM_024706.5 | c.1859G>A | p.Ter620= | stop_retained_variant | 3/3 | ENST00000300849.5 | |
ZNF668 | NM_001172669.2 | c.1928G>A | p.Ter643= | stop_retained_variant | 4/4 | ||
ZNF668 | NM_001172668.2 | c.1859G>A | p.Ter620= | stop_retained_variant | 3/3 | ||
ZNF668 | NM_001172670.2 | c.1859G>A | p.Ter620= | stop_retained_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF668 | ENST00000300849.5 | c.1859G>A | p.Ter620= | stop_retained_variant | 3/3 | 1 | NM_024706.5 | P1 | |
ENST00000622229.1 | n.1646C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.0203 AC: 3081AN: 152114Hom.: 106 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
3081
AN:
152114
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00610 AC: 977AN: 160118Hom.: 33 AF XY: 0.00462 AC XY: 395AN XY: 85564
GnomAD3 exomes
AF:
AC:
977
AN:
160118
Hom.:
AF XY:
AC XY:
395
AN XY:
85564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00186 AC: 2492AN: 1339054Hom.: 64 Cov.: 29 AF XY: 0.00164 AC XY: 1075AN XY: 654674
GnomAD4 exome
AF:
AC:
2492
AN:
1339054
Hom.:
Cov.:
29
AF XY:
AC XY:
1075
AN XY:
654674
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0203 AC: 3089AN: 152232Hom.: 106 Cov.: 32 AF XY: 0.0195 AC XY: 1452AN XY: 74428
GnomAD4 genome
?
AF:
AC:
3089
AN:
152232
Hom.:
Cov.:
32
AF XY:
AC XY:
1452
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 31, 2019 | - - |
ZNF668-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 05, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at